No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Sector Update: Health Care Stocks Softer in Late Afternoon Trading
Sector Update: Health Care
Theratechnologies Seeks FDA Approval for EGRIFTA SV Changes
Theratechnologies 10% Higher as Submits Prior Approval Supplement to FDA For Egrifta SV Distribution
Theratechnologies Has Submitted A Prior Approval Supplement To The U.S. FDA Describing The Changes Made To The Manufacturing Environment Of The Facility Where EGRIFTA SV Is Produced
Theratechnologies Receives March 2025 PDUFA Goal Date For Updated Tesamorelin F8 Formulation SBLA